Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01NCS
|
|||
| Former ID |
DIB005260
|
|||
| Drug Name |
TOL-463
|
|||
| Synonyms |
Biofilm disruptor (vaginal, vaginitis), Toltec
Click to Show/Hide
|
|||
| Indication | Bacterial vaginosis [ICD-11: MF3A; ICD-10: N89.8] | Phase 2 | [1] | |
| Vaginal disease [ICD-11: GA1Y] | Phase 1 | [2] | ||
| Company |
Toltec Pharmaceuticals Llc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02866227) TOL-463 Phase 2 Study for Vaginitis. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01812889) Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.